D Pende

Author PubWeight™ 82.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001 7.07
2 Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol 1996 4.24
3 Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med 1990 3.63
4 Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med 1995 2.75
5 Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J Exp Med 1992 2.69
6 NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur J Immunol 1999 2.59
7 Specific lysis of allogeneic cells after activation of CD3- lymphocytes in mixed lymphocyte culture. J Exp Med 1988 2.14
8 Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. Proc Natl Acad Sci U S A 1992 2.08
9 Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: definition of five distinct NK-determined allospecificities in humans. J Exp Med 1992 2.04
10 Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J Exp Med 1994 1.98
11 CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta. J Exp Med 1991 1.96
12 Human natural killer cell receptors and co-receptors. Immunol Rev 2001 1.94
13 Antigen recognition by human T cell receptor gamma-positive lymphocytes. Specific lysis of allogeneic cells after activation in mixed lymphocyte culture. J Exp Med 1988 1.84
14 Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev 1997 1.77
15 Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones. J Exp Med 1995 1.72
16 Specific recognition of human CD3-CD16+ natural killer cells requires the expression of an autosomic recessive gene on target cells. J Exp Med 1990 1.63
17 Susceptibility or resistance to lysis by alloreactive natural killer cells is governed by a gene in the human major histocompatibility complex between BF and HLA-B. Proc Natl Acad Sci U S A 1990 1.54
18 CD16 surface molecules regulate the cytolytic function of CD3CD16+ human natural killer cells. Int J Cancer 1989 1.48
19 The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity. Eur J Immunol 1999 1.47
20 Genotype-phenotype study of familial haemophagocytic lymphohistiocytosis due to perforin mutations. J Med Genet 2007 1.44
21 Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur J Immunol 1999 1.42
22 Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells. Eur J Immunol 1994 1.32
23 A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur J Immunol 1996 1.29
24 Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines. J Neuroimmunol 2000 1.28
25 Pathogenesis of haemophagocytic lymphohistiocytosis. Br J Haematol 2001 1.25
26 NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46. Eur J Immunol 2001 1.25
27 The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1 + NK cell clones. Int Immunol 1999 1.24
28 Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones. Proc Natl Acad Sci U S A 1996 1.23
29 CD3+4-8-WT31-(T cell receptor gamma+) cells and other unusual phenotypes are frequently detected among spontaneously interleukin 2-responsive T lymphocytes present in the joint fluid in juvenile rheumatoid arthritis. A clonal analysis. Eur J Immunol 1987 1.20
30 Novel Munc13-4 mutations in children and young adult patients with haemophagocytic lymphohistiocytosis. J Med Genet 2006 1.20
31 Human natural killer (NK) alloreactivity and its association with the major histocompatibility complex: ancestral haplotypes encode particular NK-defined haplotypes. J Exp Med 1993 1.18
32 The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. Eur J Immunol 1998 1.17
33 Human CD3+4-8-WT31- T lymphocyte populations expressing the putative T cell receptor gamma-gene product. A limiting dilution and clonal analysis. Eur J Immunol 1987 1.17
34 The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition. Eur J Immunol 2001 1.12
35 Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells. Proc Natl Acad Sci U S A 1995 1.10
36 p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily. Eur J Immunol 1998 1.08
37 Specific recognition by CD3- NK cells: a limiting dilution analysis of the frequency of alloreactive CD3- lymphocyte precursors. Int J Cancer Suppl 1989 1.02
38 Human natural killer cells: clonally distributed specific functions and triggering surface molecules. Lab Invest 1992 0.98
39 General role of HLA class I molecules in the protection of target cells from lysis by natural killer cells: evidence that the free heavy chains of class I molecules are not sufficient to mediate the protective effect. Int Immunol 1995 0.94
40 Specificity of human T lymphocytes expressing a gamma/delta T cell antigen receptor. Recognition of a polymorphic determinant of HLA class I molecules by a gamma/delta clone. Eur J Immunol 1989 0.93
41 Novel surface molecules involved in human NK cell activation and triggering of the lytic machinery. Int J Cancer Suppl 1992 0.91
42 Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias. Clin Exp Immunol 2009 0.88
43 Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes. AIDS 2001 0.85
44 Clonal analysis of joint fluid T lymphocytes in patients with juvenile rheumatoid arthritis. J Rheumatol 1990 0.85
45 Human natural killer cell activating receptors. Mol Immunol 2000 0.85
46 Effect of single oral doses of prednisone and deflazacort on human lymphocyte distribution and functions. Analysis with monoclonal antibodies. Adv Exp Med Biol 1984 0.84
47 Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vgamma9/Vdelta2 T cells in tumor immunity. Eur J Immunol 1997 0.84
48 Receptors for HLA class I molecules in human NK cells. Semin Immunol 1995 0.83
49 Surface receptors and functional interactions of human natural killer cells: from bench to the clinic. Cell Mol Life Sci 2003 0.82
50 Inhibitory effect of a low dose of prednisone on PHA-induced Ia antigen expression by human T cells and on proliferation of T cells stimulated with autologous PHA-T cells. Cell Immunol 1983 0.80
51 Natural killer alloeffector responses in haploidentical hemopoietic stem cell transplantation to treat high-risk leukemias. Tissue Antigens 2009 0.80
52 Both the precursors and the effectors of human lymphokine-activated killer (LAK) cells may belong to T lymphocytes. Ric Clin Lab 1987 0.80
53 T cell nature of some lymphokine-activated killer (LAK) cells. Frequency analysis of LAK precursors within human T cell populations and clonal analysis of LAK effector cells. Eur J Immunol 1986 0.80
54 Surface molecules involved in CD3-negative NK cell function. A novel molecule which regulates the activation of a subset of human NK cells. Int J Cancer Suppl 1989 0.79
55 The molecular basis of natural killer (NK) cell recognition and function. J Clin Immunol 1996 0.79
56 Human T lymphocytes in aging and malignancy: abnormalities in PHA-induced Ia antigen expression and in functional activity in autologous and allogeneic MLR. Cell Immunol 1983 0.77
57 Phenotypic and functional analysis of human CD3+ and CD3- clones with "lymphokine-activated killer" (LAK) activity. Frequent occurrence of CD3+ LAK clones which produce interleukin-2. Int J Cancer 1987 0.76
58 Inhibitory and activatory receptors for HLA class I molecules in human natural killer cells. Chem Immunol 1996 0.76
59 Human T lymphocytes expressing TCR gamma/delta. Res Immunol 1990 0.75
60 Natural killer defined haplotypes are associated with particular ancestral haplotypes: implications for bone marrow transplantation. Transplant Proc 1993 0.75
61 Subpopulations of human NK (CD3-CD16+) lymphocytes identified by monoclonal antibodies directed to clonally distributed functional surface molecules. Cytotechnology 1991 0.75
62 Analysis of CD3-associated molecules in CD4- 8- human T cell clones lacking the typical alpha/beta T cell receptor. Ric Clin Lab 1987 0.75
63 Glycoproteic nature of surface molecules of effector cells with lymphokine-activated killer (LAK) activity. Evidence that T11, T8 or T3 molecules are not involved in tumor-cell lysis by LAK effector T cells. Int J Cancer 1987 0.75
64 Analysis of the role of xenogeneic antigens in the proliferation of human T cells stimulated with autologous non-T cells and phytohemagglutinin-activated T cells. Cell Immunol 1985 0.75
65 The effects of a new phthalazine derivative (MDL 899) on human lymphocyte functions. Int J Immunopharmacol 1986 0.75
66 Ancestral haplotypes predict EC-1 alleles. Transplant Proc 1992 0.75
67 Existence of a natural killer (NK) cell repertoire for (allo)antigen recognition: definition of five distinct NK-determined allospecificities in humans. Pharmacol Res 1992 0.75
68 Role of normal adherent cells in the regulation of the autologous mixed lymphocyte reactions in humans. J Clin Immunol 1984 0.75
69 Enhancement of natural killer cytotoxicity by cis-diamminedichloroplatinum (II) in vivo and in vitro. Cancer Res 1986 0.75
70 Specificity of human T lymphocytes expressing a gamma/delta T cell antigen receptor. Recognition of a polymorphic determinant of HLA class I molecules by a gamma/delta+ clone. Curr Top Microbiol Immunol 1991 0.75
71 Heterogeneity of B cell growth factor (BCGF)-producing T cells in humans. Clonal analysis of BCGF-producing cells within T4+ and T8+ subsets and evidence for the involvement of different growth factors in different BCGF assays. Ric Clin Lab 1986 0.75
72 In vitro enhancement of the proliferative response of human T cells to autologous non-T cells by hydralazine. Immunopharmacology 1986 0.75
73 Role of distinct domains of Ia antigens in autologous and allogeneic mixed lymphocyte reactions. Behring Inst Mitt 1983 0.75
74 Decreased sensitivity of T lymphocytes to normal adherent suppressor cells in patients with head and neck cancer. Cancer Detect Prev 1984 0.75
75 Human T cells in cord blood: abnormalities in IA antigens induction by phytohemagglutinin and in autologous mixed lymphocyte reactions. Cell Immunol 1984 0.75